Free Trial
Your Rate Never Goes Up! Save $100 a Year on MarketBeat All Access
Upgrade Now
Claim MarketBeat All Access Sale Promotion

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Getinge stock logo
GNGBY
Getinge
$26.23
+0.1%		$25.09
$18.99
▼
$26.23
$7.14B0.952,218 shs320 shs
LivaNova PLC stock logo
LIVN
LivaNova
$78.14
+0.7%		$78.57
$48.82
▼
$85.76
$4.27B0.87648,459 shs387,101 shs
Masimo Corporation stock logo
MASI
Masimo
$179.95
$179.28
$125.94
▼
$179.99
$9.42B1.11964,099 shsN/A
The 10 Best High-Yield Dividend Stocks for 2026 Cover
The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Getinge stock logo
GNGBY
Getinge
+0.06%+3.51%+9.61%+9.68%+14.92%
LivaNova PLC stock logo
LIVN
LivaNova
+0.72%+1.13%+0.17%-2.14%+45.43%
Masimo Corporation stock logo
MASI
Masimo
0.00%0.00%0.00%0.00%+22.60%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Getinge stock logo
GNGBY
Getinge
$26.23
+0.1%		$25.09
$18.99
▼
$26.23
$7.14B0.952,218 shs320 shs
LivaNova PLC stock logo
LIVN
LivaNova
$78.14
+0.7%		$78.57
$48.82
▼
$85.76
$4.27B0.87648,459 shs387,101 shs
Masimo Corporation stock logo
MASI
Masimo
$179.95
$179.28
$125.94
▼
$179.99
$9.42B1.11964,099 shsN/A
The 10 Best High-Yield Dividend Stocks for 2026 Cover
The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Getinge stock logo
GNGBY
Getinge
+0.06%+3.51%+9.61%+9.68%+14.92%
LivaNova PLC stock logo
LIVN
LivaNova
+0.72%+1.13%+0.17%-2.14%+45.43%
Masimo Corporation stock logo
MASI
Masimo
0.00%0.00%0.00%0.00%+22.60%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Getinge stock logo
GNGBY
Getinge
2.00
HoldN/AN/A
LivaNova PLC stock logo
LIVN
LivaNova
2.73
Moderate Buy$87.7512.30% Upside
Masimo Corporation stock logo
MASI
Masimo
2.00
Hold$180.400.25% Upside

Current Analyst Ratings Breakdown

Latest MASI, GNGBY, and LIVN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/7/2026
LivaNova PLC stock logo
LIVN
LivaNova
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access to unlock brokerage rankings
UpgradeStrong-Buy
10/6/2026
LivaNova PLC stock logo
LIVN
LivaNova
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access to unlock brokerage rankings
Initiated CoverageEqual Weight ➝ Overweight$105.00
9/24/2026
Getinge stock logo
GNGBY
Getinge
Pareto Securities logo
Pareto Securities
Subscribe to MarketBeat All Access to unlock brokerage rankings
DowngradeStrong-Buy ➝ Hold
9/17/2026
Getinge stock logo
GNGBY
Getinge
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access to unlock brokerage rankings
DowngradeStrong-Buy ➝ Hold
9/2/2026
LivaNova PLC stock logo
LIVN
LivaNova
Piper Sandler logo
Piper Sandler
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingOverweight$87.00 ➝ $90.00
9/2/2026
Getinge stock logo
GNGBY
Getinge
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access to unlock brokerage rankings
Initiated CoverageHold
8/31/2026
Getinge stock logo
GNGBY
Getinge
Nordea Equity Research logo
Nordea Equity Research
Subscribe to MarketBeat All Access to unlock brokerage rankings
DowngradeBuy ➝ Hold
8/19/2026
LivaNova PLC stock logo
LIVN
LivaNova
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access to unlock brokerage rankings
DowngradeStrong-Buy ➝ Hold
8/18/2026
LivaNova PLC stock logo
LIVN
LivaNova
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
UpgradeHold (C) ➝ Hold (C+)
8/5/2026
LivaNova PLC stock logo
LIVN
LivaNova
Stifel Nicolaus logo
Stifel Nicolaus
Subscribe to MarketBeat All Access to unlock brokerage rankings
Set Price Target$85.00
8/5/2026
LivaNova PLC stock logo
LIVN
LivaNova
Needham & Company LLC logo
Needham & Company LLC
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetBuy$81.00 ➝ $93.00
(Data available from 10/20/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Getinge stock logo
GNGBY
Getinge
$3.57B2.00$2.00 per share13.11$11.07 per share2.37
LivaNova PLC stock logo
LIVN
LivaNova
$1.39B3.10$4.87 per share16.04$21.98 per share3.56
Masimo Corporation stock logo
MASI
Masimo
$1.56B6.05$4.65 per share38.74$13.43 per share13.40
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Getinge stock logo
GNGBY
Getinge
$230.87M$1.0520.1617.84N/A7.81%11.12%5.88%10/20/2026 (Estimated)
LivaNova PLC stock logo
LIVN
LivaNova
-$242.47M$3.3823.1218.78N/A12.82%16.35%7.76%11/4/2026 (Estimated)
Masimo Corporation stock logo
MASI
Masimo
-$151.50M-$10.54N/A28.291.824.90%31.33%13.93%N/A

Latest MASI, GNGBY, and LIVN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/4/2026Q3 2026
LivaNova PLC stock logo
LIVN
LivaNova
$1.06N/AN/AN/A$381.10 millionN/A
8/6/2026Q2 2026
LivaNova PLC stock logo
LIVN
LivaNova
$1.09$1.26+$0.17$1.93$380.50 million$390.59 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Getinge stock logo
GNGBY
Getinge
$0.291.11%N/A27.62%N/A
LivaNova PLC stock logo
LIVN
LivaNova
N/AN/AN/AN/AN/A
Masimo Corporation stock logo
MASI
Masimo
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Getinge stock logo
GNGBY
Getinge
0.26
1.31
0.74
LivaNova PLC stock logo
LIVN
LivaNova
0.22
1.45
1.21
Masimo Corporation stock logo
MASI
Masimo
0.56
2.68
1.45

Institutional Ownership

CompanyInstitutional Ownership
Getinge stock logo
GNGBY
Getinge
N/A
LivaNova PLC stock logo
LIVN
LivaNova
97.64%
Masimo Corporation stock logo
MASI
Masimo
85.96%

Insider Ownership

CompanyInsider Ownership
Getinge stock logo
GNGBY
Getinge
N/A
LivaNova PLC stock logo
LIVN
LivaNova
0.35%
Masimo Corporation stock logo
MASI
Masimo
9.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Getinge stock logo
GNGBY
Getinge
11,670272.37 millionN/ANot Optionable
LivaNova PLC stock logo
LIVN
LivaNova
3,30055.09 million54.90 millionOptionable
Masimo Corporation stock logo
MASI
Masimo
2,20052.37 million47.29 millionOptionable

Recent News About These Companies

FDA clears AFib detection feature on advanced pulse oximetry system
October 19 at 6:03 PM  |  cardiovascularbusiness.comC
Masimo’s vitals monitor scoops FDA clearance for AFib detection
October 19 at 1:02 PM  |  finance.yahoo.comhttps://finance.yahoo.com/news/masimo-vitals-monitor-scoops-fda-113948465.html
Court Orders Apple to Pay Masimo $184M
October 19 at 1:02 PM  |  ocbj.comO
Michelle Generaux - OC Executive Awards - Los Angeles Times
October 18 at 12:41 AM  |  latimes.comhttps://www.latimes.com/b2b/events/oc-executive-awards/ahmad-qazi
Masimo’s smartSET™ FDA Clearance Offers Breakthrough Innovation in Pulse Oximetry to Help Improve Critical Patient Outcomes
October 18 at 12:41 AM  |  biospace.comB
Masimo's smartSET™ FDA Clearance Offers Breakthrough Innovation in Pulse Oximetry to Help Improve Critical Patient Outcomes
October 17 at 11:56 AM  |  streetinsider.comhttps://www.streetinsider.com/PRNewswire/Masimos+smartSET%E2%84%A2+FDA+Clearance+Offers+Breakthrough+Innovation+in+Pulse+Oximetry+to+Help+Improve+Critical+Patient+Outcomes/27199180.html
Apple must pay an extra $184M to Masimo, judge says
October 9, 2026  |  massdevice.comhttps://www.massdevice.com/apple-must-pay-an-extra-184m-to-masimo-judge-says/
Apple Ordered to Pay Masimo Additional Fees in Patent Infringement Case
October 8, 2026  |  mddionline.comM
Apple Owes Masimo Another $184M in Patent Case
October 7, 2026  |  ocbj.comO
Apple Watch: Masimo patent dispute now costs Apple $818 million
October 7, 2026  |  notebookcheck.netN
Apple Ordered to Pay Masimo $184 Million in Interest, Pushing Apple Watch Patent Bill Past $818 Million
October 7, 2026  |  wi-fiplanet.comW
Apple ordered to pay Masimo $184M in interest on patent damages
October 7, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/technology/articles/apple-ordered-pay-masimo-184m-140000367.html
Apple’s $634M Patent Loss Just Got $184 Million More Expensive
October 7, 2026  |  idropnews.comI
Apple Watch patent infringement: Apple must pay an extra 184 million dollars
October 7, 2026  |  heise.deH
[$19 per unit] Apple Watch patent lawsuit, $818 million including interest
October 7, 2026  |  note.comN
Apple’s Masimo Patent Bill Rises to About $818 Million With Interest
October 6, 2026  |  macobserver.comM
Apple Ordered to Pay $184 Million USD More in Masimo Watch Patent Case
October 6, 2026  |  iphoneincanada.caI
Apple must pay Masimo an extra $184M for Apple Watch patent infringement
October 6, 2026  |  9to5mac.com9
Apple must pay an additional US$184 million to Masimo
October 6, 2026  |  mactech.comM
Apple's $634 Million Apple Watch Patent Bill Just Got Even Bigger
October 6, 2026  |  macrumors.comM

Media Sentiment Over Time

Getinge stock logo

Getinge OTCMKTS:GNGBY

$26.23 +0.02 (+0.06%)
As of 10/19/2026 02:16 PM Eastern

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, mechanical circulatory support, advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions. The company also provides surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, and drainage solutions; and operating room infrastructure equipment, anesthesia, advanced patient monitoring, operating room management, and operating room integration solutions. In addition, it offers pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices; bioreactor systems, DPTE systems, Getinge isolators, terminal sterilization products, and sterilizers; and vivarium, biohazardous materials handling solutions, labware cleaning and sterilization, upstream bioprocessing, and bioreactor preparation solutions. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia and Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.

LivaNova stock logo

LivaNova NASDAQ:LIVN

$78.14 +0.56 (+0.72%)
Closing price 10/19/2026 04:00 PM Eastern
Extended Trading
$78.21 +0.07 (+0.09%)
As of 10/19/2026 07:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

Masimo stock logo

Masimo NASDAQ:MASI

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas